LIVN News and Press, LivaNova PLC From 04/30/24

2024-04-30 12:08:52 ET More on LivaNova PLC LivaNova PLC (LIVN) Q4 2023 Earnings Call Transcript LivaNova PLC 2023 Q4 - Results - Earnings Call Presentation LivaNova issues notice to U.S. patients regarding cybersecurity incident LivaNova gains after positive...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Ahmet Tezel, Ph.D., will join the Company as Chief Innovation Officer (CINO), effective May 13, 2024. In this newly created position, Tezel will leverage his career of more than 20 years in research and deve...

2024-04-25 16:07:50 ET More on LivaNova PLC LivaNova gains after positive predictive outcome of sleep apnea study LivaNova PLC Non-GAAP EPS of $0.87 beats by $0.10, revenue of $310.1M beats by $22.4M Seeking Alpha’s Quant Rating on LivaNova PLC Read ...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that its wholly-owned U.S. subsidiary, LivaNova USA, Inc., is providing notice to U.S. patients regarding a cybersecurity incident that was initially disclosed by the Company on November 20, 2023. The in...

2024-04-22 22:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-04-14 17:56:08 ET More on Boston Scientific, CONMED, etc. ResMed: Not A Sleeper Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash Boston Scientific: The Market's Newest Mega-Cap Needs A Breather Mizuho sees ResMed as 'overwhelming ben...

2024-03-28 12:39:10 ET Read the full article on Seeking Alpha For further details see: NXST, GNTX, and COKE among the best mid-cap technical ideas - Roth MKM

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its first-quarter 2024 results on Wednesday, May 1, 2024 at 1 p.m. London time (8 a.m. Eastern Time). The Company will release its first-quarter 2024 results prior to the call. A l...

2024-03-20 10:54:39 ET More on LivaNova PLC LivaNova: Reaching End Of RECOVER And ANTHEM LivaNova PLC Non-GAAP EPS of $0.87 beats by $0.10, revenue of $310.1M beats by $22.4M LivaNova names Vladimir Makatsaria as CEO Read the full article on Seeking Alpha ...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced its OSPREY clinical study, Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Nerve Stimulation , has achieved a positive predictive outcome and will conclude enrollment earlier than anticipated...